Alzheimer’s disease disrupts nearly every major compartment inside brain cells, not just one or two. While the hallmarks most people hear about are the amyloid plaques and tau tangles that accumulate between and within neurons, the damage at the organelle level is broad and starts early. Mitochondria, the endoplasmic reticulum, lysosomes, endosomes, the Golgi apparatus, the nucleus, peroxisomes, and even smaller structures like lipid droplets and primary cilia all show measurable dysfunction in Alzheimer’s-affected tissue. Understanding which organelles break down and how they interact paints a far more complete picture of the disease than the plaque-and-tangle story alone.
Mitochondria Are Among the Earliest Casualties
Mitochondria generate the bulk of a cell’s energy through a process called oxidative phosphorylation, and neurons are extraordinarily energy-hungry. In Alzheimer’s disease, mitochondrial dysfunction has been documented across a wide range of models, from cell cultures to post-mortem human brains.1PubMed Central. ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer’s Disease The problems are not subtle. Neurons in affected brains show too much mitochondrial fission (splitting apart) and too little fusion (merging), which leaves behind a population of small, fragmented, and poorly functioning mitochondria.2PubMed Central. Defective Mitophagy in Alzheimer’s Disease – Section: Impaired Mitochondrial Dynamics in Alzheimer’s Disease Healthy cells normally clean up these damaged fragments through mitophagy, a selective form of recycling that targets broken mitochondria for destruction. In Alzheimer’s, mitophagy is also impaired, so defective mitochondria pile up instead of being cleared away.3PubMed Central. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer’s disease
The consequences go beyond mere energy shortage. Damaged mitochondria leak their own DNA into the surrounding cell, and the cell’s immune-sensing machinery treats that leaked DNA as a danger signal. This activates inflammatory pathways, including the cGAS-STING pathway, which pushes the brain toward chronic low-grade inflammation, one of the features that accelerates Alzheimer’s progression.4PubMed Central. The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer’s disease So mitochondria are not just failing to supply energy; they are actively contributing to the inflammatory environment that damages the brain further.
The Endoplasmic Reticulum and Calcium Chaos
The endoplasmic reticulum is the cell’s main factory for folding proteins into their correct shapes and a critical reservoir for calcium, which neurons use for signaling. Both of those functions go wrong in Alzheimer’s. Misfolded proteins are a hallmark of the disease, and the ER’s quality-control system, known as the unfolded protein response, becomes chronically activated. Markers of this stress response are detectable in human Alzheimer’s brains even at moderate stages of the disease and grow more pronounced as pathology worsens.5PubMed. The endoplasmic reticulum stress and unfolded protein response in Alzheimer’s disease: A calcium dyshomeostasis perspective All three branches of the unfolded protein response have been shown to be activated in neural cells exposed to ER stress conditions associated with the disease.6Genes. Role of Neurocellular Endoplasmic Reticulum Stress Response in Alzheimer’s Disease and Related Dementias Risk
The calcium side of the problem is equally damaging. The ER stores large amounts of calcium and releases it in tightly controlled bursts that neurons rely on for communication. In Alzheimer’s, calcium-release channels on the ER membrane, particularly ryanodine receptors, become dysregulated. Altered expression and function of these receptors have been reported in human AD brains, in cells carrying familial Alzheimer’s mutations, and in multiple mouse models.7PubMed Central. Ryanodine receptors: physiological function and deregulation in Alzheimer disease The protein presenilin, best known for its role in producing amyloid-beta, also regulates ryanodine receptor levels in the hippocampus. When presenilin is absent, ryanodine receptor protein levels drop, calcium release from the ER falters, and synaptic function suffers, suggesting that disrupted calcium handling may be an early event that precedes the more visible signs of disease.8PubMed Central. Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons
Where the ER and Mitochondria Meet
The endoplasmic reticulum and mitochondria are not independent actors. They physically touch at specialized contact points called mitochondria-associated ER membranes, or MAM. These junctions coordinate calcium transfer, lipid synthesis, and metabolic signaling between the two organelles. In cells from Alzheimer’s patients, MAM function is increased and the physical contact between the ER and mitochondria is significantly expanded.9PubMed Central. Mitochondria-associated ER membranes and Alzheimer disease This matters because gamma-secretase, the enzyme complex that clips amyloid precursor protein to generate amyloid-beta, is located predominantly at these contact sites. Upregulated MAM activity could therefore mean more amyloid-beta production. The ER-mitochondria interface is a place where calcium problems, energy problems, and amyloid problems converge, which makes it an unusually telling indicator of how interconnected organelle dysfunction really is in this disease.
Lysosomes and the Autophagy Breakdown
Lysosomes are the cell’s recycling centers. They break down worn-out proteins, damaged organelles, and other cellular debris using a cocktail of digestive enzymes that work best in an acidic environment. In Alzheimer’s, lysosomes lose their ability to maintain that acidity. Presenilin 1, the same protein involved in amyloid-beta generation, turns out to be essential for delivering a key proton pump component to lysosomes. When presenilin 1 is mutated or absent, the pump fails to reach its destination, lysosomes cannot acidify properly, and the digestive enzymes inside them do not activate. This stalls the entire recycling process.10PubMed Central. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations
Amyloid precursor protein itself can also sabotage lysosomes through a more direct mechanism. A fragment of the amyloid precursor protein called beta-CTF physically binds to a subunit of the proton pump and blocks it from assembling, which reduces lysosomal acidification independently of any presenilin mutation.11PubMed Central. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP βCTF This mechanism is also seen in Down syndrome, where an extra copy of the amyloid precursor protein gene raises the risk of early-onset Alzheimer’s.
The downstream effect is a massive pileup of undigested material. A continuum of lysosomal abnormalities has been identified in Alzheimer’s brains, starting with pathological endocytic responses at very early disease stages and progressing to a severe disruption of autophagy.12PubMed Central. Autophagy failure in Alzheimer’s disease–locating the primary defect The incompletely digested material accumulates inside swollen, dystrophic neurites, a feature that is distinctive to Alzheimer’s disease and not typically found in other neurodegenerative conditions.13eLife. Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer’s disease neurons
Endosomes and Cargo Sorting Gone Wrong
Endosomes are the internal sorting stations that route molecules either back to the cell surface, onward to lysosomes for degradation, or to other destinations. They are especially relevant in Alzheimer’s because amyloid precursor protein travels through the endosomal system, and it is inside endosomes that much of the cleavage producing amyloid-beta takes place. The retromer complex, a group of proteins responsible for retrieving cargo out of endosomes and sending it elsewhere, is deficient in Alzheimer’s brains. When one of its key components is depleted, amyloid precursor protein accumulates in early endosomes, encounters more of the enzyme that cleaves it, and produces more amyloid-beta. The endosomes themselves become abnormally enlarged.14PubMed Central. The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport Enlarged endosomes are actually one of the earliest cellular changes visible in Alzheimer’s, sometimes detectable even before plaques appear, which suggests that sorting problems in these compartments may help initiate the disease process rather than merely result from it.
Golgi Fragmentation
The Golgi apparatus processes, packages, and ships proteins and lipids to their correct locations in the cell. In Alzheimer’s disease, the Golgi breaks apart. Research has shown that phosphorylation of a key structural protein that holds Golgi stacks together, called GRASP65, disrupts Golgi architecture and causes it to fragment. When researchers blocked this phosphorylation, Golgi morphology was restored, and amyloid-beta production decreased.15PubMed Central. Golgi fragmentation in Alzheimer’s disease This finding is interesting because it implies a two-way relationship: amyloid-beta can cause Golgi fragmentation, and Golgi fragmentation can boost amyloid-beta production, creating a self-reinforcing cycle. Disrupted Golgi function also compromises the trafficking of many other proteins critical for maintaining synapses and dendrites, which may contribute to the widespread synaptic loss that correlates most closely with cognitive decline in Alzheimer’s patients.
The Nucleus Under Stress
The nucleus houses the cell’s DNA and is bounded by a double membrane reinforced from the inside by a meshwork of proteins called lamins. In Alzheimer’s brains, this nuclear architecture deteriorates. Post-mortem tissue from Alzheimer’s patients shows a significant expansion of the nucleoplasmic reticulum, which consists of invaginations of the nuclear envelope that extend into the interior of the nucleus. Dysfunction of the lamin-based nucleoskeleton has been shown to be causally linked to Alzheimer’s-related neurodegeneration in animal models, prompting some researchers to characterize Alzheimer’s as an “acquired neurodegenerative laminopathy.”16PubMed Central. Alzheimer’s disease: An acquired neurodegenerative laminopathy Nuclear envelope defects can scramble gene regulation and DNA repair, both of which are processes that neurons depend on for long-term survival. This line of research is still relatively young, but it adds the cell’s most central compartment to the list of organelles reshaped by the disease.
Peroxisomes and Lipid Processing
Peroxisomes handle the breakdown of very long-chain fatty acids and the synthesis of plasmalogens, a class of lipids that are abundant in brain cell membranes and involved in protecting against oxidative stress. In Alzheimer’s brains with advanced pathology, very long-chain fatty acids, which are normally broken down inside peroxisomes, accumulate in cortical tissue. At the same time, plasmalogen levels drop, consistent with peroxisomes failing at both their degradation and synthesis roles.17PubMed Central. Peroxisomal alterations in Alzheimer’s disease Plasmalogen loss matters for brain health because these lipids help maintain the fluidity and integrity of neuronal membranes. Their decline may make neurons more vulnerable to oxidative damage and membrane breakdown, adding yet another layer to the cellular deterioration in the disease.
The Proteasome Gets Jammed
Outside the lysosome, cells rely on a separate degradation system called the proteasome to break down individual proteins that have been tagged for destruction. In Alzheimer’s, amyloid-beta oligomers, the small clusters of amyloid-beta that many researchers now believe are more toxic than the large plaques, directly inhibit proteasome activity. In young mouse models of Alzheimer’s, impaired proteasome function correlates with the first detection of intracellular amyloid-beta oligomers. When researchers experimentally blocked the proteasome in pre-pathological mice, both amyloid-beta and tau accumulation increased sharply, highlighting how proteasome impairment accelerates the buildup of both hallmark proteins.18PubMed Central. Abeta inhibits the proteasome and enhances amyloid and tau accumulation This creates a vicious cycle: amyloid-beta poisons the proteasome, and a poisoned proteasome lets more amyloid-beta and tau accumulate.
Ribosomes and the Protein Synthesis Machinery
The cell’s protein-making equipment is also compromised. Oxidized RNA, including messenger RNA, ribosomal RNA, and transfer RNA, has been identified in the brains of Alzheimer’s patients at the prodromal stage, before full clinical dementia develops. Oxidized RNA leads to slowed or aberrant protein synthesis, meaning that the instructions for building proteins become garbled before the cell even begins assembling them.19PubMed Central. RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs Because neurons require enormous amounts of new protein to maintain their synapses and long axons, impaired translation has outsized consequences for brain cells compared to most other cell types.
Microtubules and the Axonal Highway
Microtubules are the internal scaffolding that gives neurons their shape and serves as the railway tracks along which cargo, from mitochondria to neurotransmitter vesicles, is transported across distances that can be remarkable for a single cell. Tau protein normally stabilizes these tracks, but in Alzheimer’s, tau becomes abnormally phosphorylated, detaches from microtubules, and aggregates into the tangles characteristic of the disease. The destabilized microtubules can no longer efficiently support transport by motor proteins like kinesin-1, and axonal transport grinds down.20PubMed Central. Unraveling the interplay of kinesin-1, tau, and microtubules in neurodegeneration associated with Alzheimer’s disease This is one reason the autophagosome pileups described earlier tend to occur specifically in axons: even if the cell creates autophagosomes normally, they cannot travel back to the cell body where lysosomes are concentrated, so digestion never gets completed.
Lipid Droplets in Immune Cells of the Brain
Lipid droplets are storage organelles for fats, and they have recently attracted attention in Alzheimer’s research. In mouse models of tauopathy, microglia, the brain’s resident immune cells, accumulate large numbers of lipid droplets. Imaging experiments have shown that tauopathy brains exhibit heightened fat synthesis and impaired fat turnover. The problem appears to originate in neurons: tau pathology in neurons leads to an excess of unsaturated lipids, which are then transferred to nearby microglia. Once loaded with these lipids, microglia develop oxidative stress, become inflamed, and lose their ability to phagocytose, meaning they can no longer clean up debris the way healthy microglia do.11PubMed Central. Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP βCTF This neuron-to-microglia lipid transfer is an example of how organelle dysfunction in one cell type can propagate damage to another.
Primary Cilia as Sensory Antennae
Primary cilia are antenna-like projections on the cell surface that detect signals from the surrounding environment. They are built on a microtubule core, and their dysfunction has been linked to various age-related conditions. In the mature brain, anomalies in primary cilia function and morphology are closely associated with key Alzheimer’s pathologies. Because cilia help neurons sense growth factors, respond to signaling molecules, and maintain their position within neural circuits, their degradation may compound the communication breakdowns that drive cognitive decline. Research on cilia in Alzheimer’s is still in its early stages, but the emerging link adds yet another organelle to the growing inventory of structures reshaped by the disease.
Why So Many Organelles Fail Together
A reasonable question is why a single disease manages to damage so many different compartments at once. Part of the answer is that organelles are not independent rooms in a house; they form a deeply interconnected network. Calcium released improperly from the ER floods into mitochondria, impairing their function. Damaged mitochondria that should be cleared through mitophagy cannot be digested because lysosomes are too alkaline to activate their enzymes. Undigested autophagosomes clog axons because microtubule transport is hobbled by tau pathology. Golgi fragmentation compromises the delivery of lysosomal enzymes that might otherwise rescue the recycling system. And amyloid-beta, which begins as a normal protein processed through endosomes and the Golgi, poisons the proteasome and lysosomes that would ordinarily keep its levels in check. These feedback loops mean that a problem starting in any one organelle quickly cascades into others.
The practical result is that Alzheimer’s therapies focused on clearing a single protein or rescuing a single organelle may face an uphill battle if the downstream damage to multiple compartments is already entrenched. This has spurred interest in strategies that target organelle quality control broadly. Compounds that enhance mitophagy, such as urolithin A and NAD+ precursors, have been shown in lab models to suppress both amyloid- and tau-driven mitochondrial and synaptic dysfunction.21PubMed Central. Are mitophagy enhancers therapeutic targets for Alzheimer’s disease? Whether these agents will translate into clinical benefit remains an open question, but the logic of targeting organelle maintenance rather than a single protein is gaining traction precisely because the organelle damage in Alzheimer’s is so pervasive.